SYNALAR

This brand name is authorized in United States. It is also authorized in Canada, Cyprus, Hong Kong SAR China, Mexico, South Africa, Spain, UK.

Active ingredients

The drug SYNALAR contains one active pharmaceutical ingredient (API):

1	Fluocinolone UNII 0CD5FD6S2M - FLUOCINOLONE ACETONIDE
	Fluocinolone acetonide is a synthetic fluorinated corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Fluocinolone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AC04	Fluocinolone acetonide	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02162512
ES	Centro de información online de medicamentos de la AEMPS	37290, 39411, 44205, 46441, 49275
GB	Medicines & Healthcare Products Regulatory Agency	115073, 21569, 21586, 21589, 21604, 21620, 21647, 83885
HK	Department of Health Drug Office	06809, 06829, 06832
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	55749
US	FDA, National Drug Code	43538-900, 43538-910, 43538-920
ZA	Health Products Regulatory Authority	B/13.4.1/133